National Vaccine
Information Center

Your Health. Your Family. Your Choice.

MedAlerts Home
Search Results

This is VAERS ID 27348

History of Changes from the VAERS Wayback Machine

Already in VAERS on 12/31/2003

VAERS ID: 27348
VAERS Form:
Age:22.0
Sex:Male
Location:Pennsylvania
Vaccinated:1990-11-06
Onset:1990-11-12
Submitted:0000-00-00
Entered:1991-01-10
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: RECOMBIVAX HB / MSD - / - - / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: FEVER, NAUSEA, DIARRHEA, HEPATITIS, LIVER FUNC ABNORM

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: G-6-pd deficiency
Allergies:
Diagnostic Lab Data: TSB 15NOV90 8.9; SGOT 15NOV90 370; SGPT 15NOV90 255; Eosinophils 15NOV90 8%; LDH 15NOV90 344; Serum alk phos 15NOV90 154. ER labs: TTL Bili 8.9, SGOT 370, SGPT 255, LDH 344 & SE ALK PHOS 154. CBC:peripheral eosinophilia of 8% & Hgb stabl
CDC 'Split Type':

Write-up: Pt w/ G-6-PD vaccinated w/Recombivax HB. Developed nausea, vomiting, diarrhea & a fever 103. Admitted to ER. Dx: hepatitis based on labs. Hep A, Hep B, Hep C and Epstein-Barr virus were neg. Gradual improvement; at 4 wks, LFT''s wnl.


Changed on 12/8/2009

VAERS ID: 27348 Before After
VAERS Form:
Age:22.0
Sex:Male
Location:Pennsylvania
Vaccinated:1990-11-06
Onset:1990-11-12
Submitted:0000-00-00
Entered:1991-01-10 1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: RECOMBIVAX HB HEP B (RECOMBIVAX HB) / MSD MERCK & CO. INC. - / - - / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Diarrhoea, Hepatic function abnormal, Hepatitis, Nausea, Pyrexia, Vomiting, FEVER, NAUSEA, DIARRHEA, HEPATITIS, LIVER FUNC ABNORM

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? Yes
Previous Vaccinations:
Other Medications:
Current Illness:
Preexisting Conditions: G-6-pd deficiency
Allergies:
Diagnostic Lab Data: TSB 15NOV90 8.9; SGOT 15NOV90 370; SGPT 15NOV90 255; Eosinophils 15NOV90 8%; LDH 15NOV90 344; Serum alk phos 15NOV90 154. ER labs: TTL Bili 8.9, SGOT 370, SGPT 255, LDH 344 & SE ALK PHOS 154. CBC:peripheral eosinophilia of 8% & Hgb stabl
CDC 'Split Type': (blank) WAES90102791

Write-up: Pt w/ G-6-PD vaccinated w/Recombivax HB. Developed nausea, vomiting, diarrhea & a fever 103. Admitted to ER. Dx: hepatitis based on labs. Hep A, Hep B, Hep C and Epstein-Barr virus were neg. Gradual improvement; at 4 wks, LFT''s wnl.


Changed on 5/14/2017

VAERS ID: 27348 Before After
VAERS Form:
Age:22.0
Sex:Male
Location:Pennsylvania
Vaccinated:1990-11-06
Onset:1990-11-12
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / - - / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Diarrhoea, Hepatic function abnormal, Hepatitis, Nausea, Pyrexia, Vomiting

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? Yes
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions: G-6-pd deficiency
Allergies:
Diagnostic Lab Data: TSB 15NOV90 8.9; SGOT 15NOV90 370; SGPT 15NOV90 255; Eosinophils 15NOV90 8%; LDH 15NOV90 344; Serum alk phos 15NOV90 154. ER labs: TTL Bili 8.9, SGOT 370, SGPT 255, LDH 344 & SE ALK PHOS 154. CBC:peripheral eosinophilia of 8% & Hgb stabl
CDC 'Split Type': WAES90102791

Write-up: Pt w/ G-6-PD vaccinated w/Recombivax HB. Developed nausea, vomiting, diarrhea & a fever 103. Admitted to ER. Dx: hepatitis based on labs. Hep A, Hep B, Hep C and Epstein-Barr virus were neg. Gradual improvement; at 4 wks, LFT''s wnl.


Changed on 9/14/2017

VAERS ID: 27348 Before After
VAERS Form:(blank) 1
Age:22.0
Sex:Male
Location:Pennsylvania
Vaccinated:1990-11-06
Onset:1990-11-12
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / - UNK - / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Diarrhoea, Hepatic function abnormal, Hepatitis, Nausea, Pyrexia, Vomiting

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? Yes
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions: G-6-pd deficiency
Allergies:
Diagnostic Lab Data: TSB 15NOV90 8.9; SGOT 15NOV90 370; SGPT 15NOV90 255; Eosinophils 15NOV90 8%; LDH 15NOV90 344; Serum alk phos 15NOV90 154. ER labs: TTL Bili 8.9, SGOT 370, SGPT 255, LDH 344 & SE ALK PHOS 154. CBC:peripheral eosinophilia of 8% & Hgb stabl
CDC 'Split Type': WAES90102791

Write-up: Pt w/ G-6-PD vaccinated w/Recombivax HB. Developed nausea, vomiting, diarrhea & a fever 103. Admitted to ER. Dx: hepatitis based on labs. Hep A, Hep B, Hep C and Epstein-Barr virus were neg. Gradual improvement; at 4 wks, LFT''s wnl.


Changed on 2/14/2018

VAERS ID: 27348 Before After
VAERS Form:1
Age:22.0
Sex:Male
Location:Pennsylvania
Vaccinated:1990-11-06
Onset:1990-11-12
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / UNK - / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Diarrhoea, Hepatic function abnormal, Hepatitis, Nausea, Pyrexia, Vomiting

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? Yes
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions: G-6-pd deficiency
Allergies:
Diagnostic Lab Data: TSB 15NOV90 8.9; SGOT 15NOV90 370; SGPT 15NOV90 255; Eosinophils 15NOV90 8%; LDH 15NOV90 344; Serum alk phos 15NOV90 154. ER labs: TTL Bili 8.9, SGOT 370, SGPT 255, LDH 344 & SE ALK PHOS 154. CBC:peripheral eosinophilia of 8% & Hgb stabl
CDC 'Split Type': WAES90102791

Write-up: Pt w/ G-6-PD vaccinated w/Recombivax HB. Developed nausea, vomiting, diarrhea & a fever 103. Admitted to ER. Dx: hepatitis based on labs. Hep A, Hep B, Hep C and Epstein-Barr virus were neg. Gradual improvement; at 4 wks, LFT''s wnl.


Changed on 6/14/2018

VAERS ID: 27348 Before After
VAERS Form:1
Age:22.0
Sex:Male
Location:Pennsylvania
Vaccinated:1990-11-06
Onset:1990-11-12
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / UNK - / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Diarrhoea, Hepatic function abnormal, Hepatitis, Nausea, Pyrexia, Vomiting

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? Yes
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions: G-6-pd deficiency
Allergies:
Diagnostic Lab Data: TSB 15NOV90 8.9; SGOT 15NOV90 370; SGPT 15NOV90 255; Eosinophils 15NOV90 8%; LDH 15NOV90 344; Serum alk phos 15NOV90 154. ER labs: TTL Bili 8.9, SGOT 370, SGPT 255, LDH 344 & SE ALK PHOS 154. CBC:peripheral eosinophilia of 8% & Hgb stabl
CDC 'Split Type': WAES90102791

Write-up: Pt w/ G-6-PD vaccinated w/Recombivax HB. Developed nausea, vomiting, diarrhea & a fever 103. Admitted to ER. Dx: hepatitis based on labs. Hep A, Hep B, Hep C and Epstein-Barr virus were neg. Gradual improvement; at 4 wks, LFT''s wnl.


Changed on 8/14/2018

VAERS ID: 27348 Before After
VAERS Form:1
Age:22.0
Sex:Male
Location:Pennsylvania
Vaccinated:1990-11-06
Onset:1990-11-12
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / UNK - / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Diarrhoea, Hepatic function abnormal, Hepatitis, Nausea, Pyrexia, Vomiting

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? Yes
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions: G-6-pd deficiency
Allergies:
Diagnostic Lab Data: TSB 15NOV90 8.9; SGOT 15NOV90 370; SGPT 15NOV90 255; Eosinophils 15NOV90 8%; LDH 15NOV90 344; Serum alk phos 15NOV90 154. ER labs: TTL Bili 8.9, SGOT 370, SGPT 255, LDH 344 & SE ALK PHOS 154. CBC:peripheral eosinophilia of 8% & Hgb stabl
CDC 'Split Type': WAES90102791

Write-up: Pt w/ G-6-PD vaccinated w/Recombivax HB. Developed nausea, vomiting, diarrhea & a fever 103. Admitted to ER. Dx: hepatitis based on labs. Hep A, Hep B, Hep C and Epstein-Barr virus were neg. Gradual improvement; at 4 wks, LFT''s wnl.


Changed on 9/14/2018

VAERS ID: 27348 Before After
VAERS Form:1
Age:22.0
Sex:Male
Location:Pennsylvania
Vaccinated:1990-11-06
Onset:1990-11-12
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / UNK - / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Diarrhoea, Hepatic function abnormal, Hepatitis, Nausea, Pyrexia, Vomiting

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? Yes
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions: G-6-pd deficiency
Allergies:
Diagnostic Lab Data: TSB 15NOV90 8.9; SGOT 15NOV90 370; SGPT 15NOV90 255; Eosinophils 15NOV90 8%; LDH 15NOV90 344; Serum alk phos 15NOV90 154. ER labs: TTL Bili 8.9, SGOT 370, SGPT 255, LDH 344 & SE ALK PHOS 154. CBC:peripheral eosinophilia of 8% & Hgb stabl
CDC 'Split Type': WAES90102791

Write-up: Pt w/ G-6-PD vaccinated w/Recombivax HB. Developed nausea, vomiting, diarrhea & a fever 103. Admitted to ER. Dx: hepatitis based on labs. Hep A, Hep B, Hep C and Epstein-Barr virus were neg. Gradual improvement; at 4 wks, LFT''s wnl.


Changed on 10/14/2018

VAERS ID: 27348 Before After
VAERS Form:1
Age:22.0
Sex:Male
Location:Pennsylvania
Vaccinated:1990-11-06
Onset:1990-11-12
Submitted:0000-00-00
Entered:1991-01-08
Vaccin­ation / Manu­facturer Lot / Dose Site / Route
HEP: HEP B (RECOMBIVAX HB) / MERCK & CO. INC. - / UNK - / IM

Administered by: Unknown      Purchased by: Unknown
Symptoms: Diarrhoea, Hepatic function abnormal, Hepatitis, Nausea, Pyrexia, Vomiting

Life Threatening? No
Birth Defect? No
Died? No
Permanent Disability? No
Recovered? No
Office Visit (V2.0)? No
ER or Office Visit (V1.0)? No
ER or ED Visit (V2.0)? No
Hospitalized? Yes, days:     Extended hospital stay? Yes
Previous Vaccinations: ~ ()~~~In patient
Other Medications:
Current Illness:
Preexisting Conditions: G-6-pd deficiency
Allergies:
Diagnostic Lab Data: TSB 15NOV90 8.9; SGOT 15NOV90 370; SGPT 15NOV90 255; Eosinophils 15NOV90 8%; LDH 15NOV90 344; Serum alk phos 15NOV90 154. ER labs: TTL Bili 8.9, SGOT 370, SGPT 255, LDH 344 & SE ALK PHOS 154. CBC:peripheral eosinophilia of 8% & Hgb stabl
CDC 'Split Type': WAES90102791

Write-up: Pt w/ G-6-PD vaccinated w/Recombivax HB. Developed nausea, vomiting, diarrhea & a fever 103. Admitted to ER. Dx: hepatitis based on labs. Hep A, Hep B, Hep C and Epstein-Barr virus were neg. Gradual improvement; at 4 wks, LFT''s wnl.

New Search

Link To This Search Result:

https://medalerts.org/vaersdb/findfield.php?IDNUMBER=27348&WAYBACKHISTORY=ON


Copyright © 2020 National Vaccine Information Center. All rights reserved.
21525 Ridgetop Circle, Suite 100, Sterling, VA 20166